Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Feb 2023: Patents and Drug Pricing Make Front-Page News
Big Pharma fights patent disclosure demand from investors
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Jan 2023: Patent Reform And Lower Drug Prices Should Be Bipartisan Priorities
Patent reform and lower drug prices should be bipartisan priorities
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
Dec 2022: Year in Review – Historic Progress on Patent Reform
How AbbVie denied Americans access to fair competition for Humira
Nov 2022: MacArthur, Growing Momentum, and Much More
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe